Vernal Biosciences
Burlington
About Vernal Biosciences
Vernal Biosciences specializes in high-purity mRNA for research and clinical use. Its platform processes and analytical methods will remove the guesswork and lengthy development cycles inherent to many manufacturing processes in the advanced therapeutics field. Its high-purity supply and services provide the flexibility to perform proper drug discovery and development without risking the buildout of costly teams and facilities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $41.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2023)
- Website: vernal.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/vernal-biosciences-22783 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.